Torrent Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
TORNTPHARM
Pharmaceuticals
Share Price NSE
₹4029.20
▼
-22.10 (-0.55%)
Share Price BSE
₹4027.60
▼
-21.60 (-0.53%)
Track Torrent Pharmaceuticals share price live with TickJournal's free stock screener.
Analyze Torrent Pharmaceuticals share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Torrent Pharmaceuticals Market Cap
₹134,945.00 Cr.
TORNTPHARM P/E Ratio (TTM)
59.42
Torrent Pharmaceuticals P/B Ratio
15.98
EPS (TTM)
₹56.47
Dividend Yield
0.15%
Debt to Equity
0.50
TORNTPHARM 52 Week High
₹4446.00
Torrent Pharmaceuticals 52 Week Low
₹3127.80
Operating Margin
31.00%
Profit Margin
17.23%
TORNTPHARM Revenue (TTM)
₹2,891.00
EBITDA
₹872.00
Net Income
₹498.00
Total Assets
₹14,990.00
Total Equity
₹7,591.00
Torrent Pharmaceuticals Share Price History - Stock Screener Chart
Screen TORNTPHARM historical share price movements with interactive charts. Analyze price trends and patterns.
Torrent Pharmaceuticals Company Profile - Fundamental Screener
Screen Torrent Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TORNTPHARM shares.
Torrent Pharmaceuticals Limited is a leading Indian pharmaceutical company with a global presence. It specializes in cardiovascular, central nervous system, vitamins and nutrients, gastro-intestinal, and anti-diabetes therapies. The company operates through wholly-owned subsidiaries in over 40 countries, with major operations in the US, Germany, and Brazil. Torrent Pharmaceuticals has manufacturing...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Samir Mehta
ISIN
INE685A01028
Website
https://www.torrentpharma.com
Torrent Pharmaceuticals Balance Sheet Screener
Screen TORNTPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14,990 | 15,061 | 15,012 | 13,100 | 14,075 | 14,010 | 14,121 | 14,243 | 9,702 | 9,058 |
| Current Assets | 5,623 | 5,612 | 5,314 | 5,165 | 5,522 | 4,979 | 5,038 | 5,262 | 4,880 | 4,688 |
| Fixed Assets | 7,947 | 8,138 | 8,122 | 6,423 | 7,065 | 7,533 | 7,748 | 7,855 | 3,688 | 2,859 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2,682 | 2,779 | 3,367 | 2,732 | 3,346 | 3,732 | 4,231 | 4,418 | 2,613 | 2,278 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 7,591 | 6,856 | 6,198 | 5,953 | 5,837 | 4,823 | 4,724 | 4,623 | 4,351 | 3,495 |
| Share Capital | 169 | 169 | 169 | 85 | 85 | 85 | 85 | 85 | 85 | 85 |
| Reserves & Surplus | 7,422 | 6,687 | 6,029 | 5,868 | 5,753 | 4,739 | 4,640 | 4,538 | 4,266 | 3,410 |
Torrent Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Torrent Pharmaceuticals income statement and profit fundamentals.
Analyze TORNTPHARM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Torrent Pharmaceuticals share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,891 | 3,091 | 3,219 | 3,238 | 2,726 | 2,839 | 2,815 | 2,795 | 2,461 | 2,582 | 2,654 | 2,746 | 2,160 | 2,322 | 2,277 |
| Expenses | 2,019 | 2,146 | 2,232 | 2,225 | 1,862 | 1,955 | 1,950 | 1,895 | 1,764 | 1,800 | 1,835 | 1,863 | 2,055 | 1,635 | 1,612 |
| EBITDA | 872 | 945 | 987 | 1,013 | 864 | 884 | 865 | 900 | 697 | 782 | 819 | 883 | 105 | 687 | 665 |
| Operating Profit % | 31.00% | 31.00% | 31.00% | 32.00% | 31.00% | 31.00% | 31.00% | 31.00% | 28.00% | 29.00% | 30.00% | 31.00% | 2.00% | 29.00% | 29.00% |
| Depreciation | 201 | 201 | 204 | 206 | 203 | 197 | 198 | 199 | 196 | 191 | 201 | 213 | 162 | 155 | 163 |
| Interest | 56 | 56 | 48 | 45 | 80 | 75 | 64 | 57 | 107 | 103 | 91 | 80 | 57 | 55 | 69 |
| Profit Before Tax | 665 | 738 | 791 | 814 | 631 | 656 | 661 | 691 | 433 | 531 | 559 | 631 | -87 | 532 | 463 |
| Tax | 167 | 190 | 200 | 179 | 182 | 199 | 208 | 188 | 146 | 153 | 173 | 188 | 31 | 178 | 151 |
| Net Profit | 498 | 548 | 591 | 635 | 449 | 457 | 453 | 503 | 287 | 378 | 386 | 443 | -118 | 354 | 312 |
| EPS | 14.71 | 16.19 | 17.54 | 18.77 | 13.27 | 13.51 | 13.37 | 14.88 | 8.48 | 11.18 | 11.39 | 13.10 | -6.97 | 20.90 | 9.22 |
Torrent Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen TORNTPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 2,585 | 3,266 | 2,368 | 1,803 | 2,005 | 1,393 | 1,798 | 894 | 1,009 | 2,742 |
| Investing Activities | -549 | -160 | -2,335 | -196 | -444 | 229 | -246 | -4,677 | -798 | -870 |
| Financing Activities | -2,298 | -2,780 | 77 | -1,781 | -1,651 | -1,549 | -1,314 | 3,417 | -193 | -1,435 |
| Net Cash Flow | -262 | 327 | 110 | -174 | -89 | 73 | 238 | -366 | 18 | 438 |
Torrent Pharmaceuticals Shareholding Pattern Screener
See Torrent Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Torrent Pharmaceuticals promoter holding and ownership changes for TORNTPHARM on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.31% | 68.31% | 68.31% | 68.31% | 71.25% | 71.25% | 71.25% | 68.31% |
| FII Holding | 16.31% | 16.09% | 15.92% | 16.13% | 14.14% | 14.22% | 14.46% | 16.17% |
| DII Holding | 8.35% | 8.65% | 9.28% | 9.14% | 7.26% | 7.27% | 7.08% | 8.35% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 4.51% | 4.44% | 4.08% | 4.03% | 4.09% | 3.98% | 4.34% | 4.61% |
| Other Holding | 2.52% | 2.50% | 2.41% | 2.38% | 3.27% | 3.28% | 2.87% | 2.56% |
| Shareholder Count | 86,005 | 81,856 | 78,226 | 76,214 | 71,154 | 74,765 | 79,848 | 85,035 |
Torrent Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Torrent Pharmaceuticals dividend history with payout and yield data.
View Torrent Pharmaceuticals dividend details including ex-dates and amounts for TORNTPHARM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹32.00 | 0.76% |
| 2024-March | ₹28.00 | 0.87% |
| 2023-March | ₹22.00 | 0.85% |
| 2022-March | ₹48.00 | 3.12% |
| 2021-March | ₹35.00 | 2.51% |
| 2020-March | ₹32.00 | 2.51% |
| 2019-March | ₹17.00 | 1.72% |
| 2018-March | ₹14.00 | 1.44% |
| 2017-March | ₹14.00 | 2.24% |
Torrent Pharmaceuticals Stock Index Membership
See which indices include Torrent Pharmaceuticals stock.
Check TORNTPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE 200 EQUAL WEIGHT
BSE INDEX BSE HC
BSE INDEX BSE200
BSE INDEX BSE500
BSE INDEX BSEMOI
BSE INDEX BSEQUI
BSE INDEX LCTMCI
BSE INDEX LMI250
BSE INDEX MIDCAP
BSE INDEX MIDSEL
NIFTY 100
NIFTY 200
NIFTY 500
NIFTY ALPHA QUALITY LOW-VOLATILITY 30
NIFTY ALPHALOWVOL
NIFTY HEALTHCARE
NIFTY INDIA MFG
NIFTY LARGEMID250
NIFTY LOW VOLATILITY 50
NIFTY NEXT 50
NIFTY PHARMA
NIFTY TOTAL MKT
NIFTY100 ALPHA 30
NIFTY100 ENHANCED ESG
NIFTY100 EQL WGT
NIFTY100 ESG
NIFTY100 LOWVOL30
NIFTY200MOMENTM30
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
Torrent Pharmaceuticals Market Events Screener - Corporate Actions
Get Torrent Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Torrent Pharmaceuticals stock events that may affect TORNTPHARM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-18 | 2026-02-19 | Dividend | ₹ 29.00 /share | 3.14% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 2.11% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -0.67% |
| 2025-07-28 | 2025-07-28 | Annual General Meeting | NA | 8.09% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 2.33% |
| 2025-06-20 | 2025-06-20 | Dividend | ₹ 6.00 /share | -4.20% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 2.01% |
| 2025-01-31 | 2025-02-01 | Dividend | ₹ 26.00 /share | -0.21% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | -0.25% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -6.75% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 6.63% |
| 2024-06-21 | 2024-06-21 | Dividend | ₹ 6.00 /share | 6.18% |
| 2024-02-12 | 2024-02-12 | Dividend | ₹ 22.00 /share | 5.77% |
| 2023-06-23 | 2023-06-23 | Dividend | ₹ 8.00 /share | 9.19% |
| 2023-02-03 | 2023-02-03 | Dividend | ₹ 14.00 /share | -2.75% |
Torrent Pharmaceuticals Competitors Screener - Peer Comparison
Screen TORNTPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.12 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 62.72 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 59.42 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,955 | 22.29 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.40 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.27 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.30 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.73 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.27 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.95 | 13,458 | 3.70% | 2,216 | 42.54 |
Torrent Pharmaceuticals Company Announcements - News Screener
Screen TORNTPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-03 | Sale Of Equity Shares Of UNM Foundation (Section 8 Company) Associate Company | - |
| 2026-04-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-01 | Closure of Trading Window | - |
| 2026-03-31 | Notice To Shareholders For NCLT Convened Meeting | - |
| 2026-03-31 | Notice To Equity Shareholders For NCLT Convened Meeting | - |
| 2026-03-25 | Announcement Under Regulation 30 Of SEBI (LODR) - Corrigendum | - |
| 2026-03-24 | Announcement Under Regulation 30 Of SEBI LODR - NCLT Order | - |
| 2026-03-21 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-20 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Date of payment of Dividend | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Dividend Updates | - |
| 2026-02-13 | Corporate Action-Board approves Dividend | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Board Meeting Dated 13-Feb-26 | - |
| 2026-02-13 | Results | - |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |